CAIPO Centro para la atención integral del paciente oncológico

San Miguel de Tucumán 4000

0 studies enrolling now · 2 studies all time

What they study most

Locally Recurrent Breast Cancer, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer — Stopped early
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early